The incidence and the mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma

被引：0
|
作者：
Shinohara, N.
Takahashi, M.
Kamishima, T.
Ikushima, H.
Otsuka, N.
Ishizu, A.
Sazawa, A.
Kanayama, H.
Nonomura, K.
机构：
[1] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Univ Tokushima, Dept Urol, Grad Sch, Tokushima 770, Japan
[3] Hokkaido Univ Hosp, Dept Radiol, Sapporo, Hokkaido 060, Japan
[4] Tokushima Univ Hosp, Dept Radiol, Tokushima, Japan
[5] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan
[6] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan
[7] Hokkaido Univ, Grad Sch Med, Deaprtment Urol, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15097
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
  • [42] NT-proBNP for detection of sunitinib-induced cardiac toxicity in renal cell carcinoma
    Bergler-Klein, J.
    Bojic, M.
    Vogl, U.
    Lamm, W.
    Bojic, A.
    Binder, T.
    Maurer, G.
    Zielinski, C.
    Schmidinger, M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1096 - 1096
  • [43] Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
    Diekstra, Meta H. M.
    Liu, Xiaoyan
    Swen, Jesse J.
    Boven, Epie
    Castellano, Daniel
    Gelderblom, Hans
    Mathijssen, Ron H. J.
    Rodriguez-Antona, Cristina
    Garcia-Donas, Jesus
    Rini, Brian I.
    Guchelaar, Henk-Jan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) : 1477 - 1484
  • [44] Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency
    Khan, G.
    Golshayan, A.
    Elson, P.
    Wood, L.
    Garcia, J.
    Bukowski, R.
    Rini, B.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1618 - 1622
  • [45] Continuous therapy with sunitinib in patients with metastatic renal cell carcinoma
    Kahl, Christoph
    Hilgendorf, Inken
    Freund, Mathias
    Casper, Jochen
    ONKOLOGIE, 2008, 31 (8-9): : 485 - 485
  • [46] Tolerance of Sunitinib in Dialyzed Patients With Metastatic Renal Cell Carcinoma
    Vickers, Michael M.
    Heng, Daniel Y.
    Hemmelgarn, Brenda
    Eigl, Bernhard J.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (03) : E104 - E106
  • [47] Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience
    Ansari, Jawaher
    Fatima, Arfeen
    Fernando, Kieran
    Collins, Stuart
    James, Nicholas D.
    Porfiri, Emilio
    ONCOLOGY REPORTS, 2010, 24 (02) : 507 - 510
  • [48] Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma
    Lim, Sung Hee
    Hwang, In Gyu
    Ji, Jun Ho
    Oh, Sung Yong
    Yi, Jun Ho
    Lim, Do Hyoung
    Lim, Ho Yeong
    Lee, Su Jin
    Park, Se Hoon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (01) : 61 - 67
  • [49] Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    Figlin, Robert A.
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kim, Sindy T.
    Baum, Charles M.
    Kaftan, Michael W.
    CANCER, 2008, 113 (07) : 1552 - 1558
  • [50] Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Rini, Brian I.
    Tamaskar, Ila
    Shaheen, Phillip
    Salas, Renee
    Garcia, Jorge
    Wood, Laura
    Reddy, Sethu
    Dreicer, Robert
    Bukowski, Ronald M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (01): : 81 - 83
12345